The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus
Open accessAbstract
Infectious diseases are the second most important cause of human death worldwide; Staphylococcus aureus (S. aureus) is a very common human pathogenic microorganism that can trigger a variety of infectious diseases, such as skin and soft tissue infections, endocarditis, osteomyelitis, bacteremia and lethal pneumonia. Moreover, according to the sensitivity to antibiotic drugs, S. aureus can be divided into methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). In recent decades, due to the evolution of bacteria and the abuse of antibiotics, the drug resistance of S. aureus has gradually increased, the infection rate of MRSA has increased worldwide, and the clinical anti-infective treatment for MRSA has become more difficult. Accumulating evidence has demonstrated that the resistance mechanisms of S. aureus are very complex, especially for MRSA, which is resistant to many kinds of antibiotics. Therefore, understanding the drug resistance of MRSA in a timely manner and elucidating its drug resistance mechanism at the molecular level are of great significance for the treatment of S. aureus infection. A large number of researchers believe that analyzing the molecular characteristics of S. aureus can help provide a basis for designing effective prevention and treatment measures against hospital infections caused by S. aureus and further monitor the evolution of S. aureus. This paper reviews the research status of MSSA and MRSA, the detailed mechanisms of the intrinsic antibiotic resistance and the acquired antibiotic resistance, the advanced research on anti-MRSA antibiotics and novel therapeutic strategies for MRSA treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
Klevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726 · cited 1×
“Methicillin-Resistant Staphylococcus Aureus (MRSA) Fleming discovered penicillin in the 1940s and pioneered the era of antibiotics for infection treatment (Klevens et al., 2007; Klein et al., 2017).”
BackgroundWaves of resistance: Staphylococcus aureus in the antibiotic era
Chambers, H. F., & DeLeo, F. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2200 · Cited by 2,718
Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology
Lakhundi, S., & Zhang, K. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00020-18 · Cited by 1,637
Persistent bacterial infections and persister cells
Fisher, R. A., Gollan, B., & Helaine, S. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.42 · Cited by 1,243
Phage therapy: An alternative to antibiotics in the age of multi-drug resistance
Lin, D. M., Koskella, B., & Lin, H. C. (2017) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v8.i3.162 · Cited by 1,135
Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-09 · Cited by 962
Regulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and Disease
Bogdan, A. R., Miyazawa, M., Hashimoto, K., & Tsuji, Y. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.11.012 · Cited by 893
Antibiotic resistance in Staphylococcus aureus. Current status and future prospects
Foster, T. J. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux007 · Cited by 845
Multidrug Tolerance of Biofilms and Persister Cells
Lewis, K. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-75418-3_6 · Cited by 804
Hassoun, A., Linden, P. K., & Friedman, B. (2017) · Critical Care · doi:10.1186/s13054-017-1801-3 · Cited by 604
Mechanisms of vancomycin resistance in Staphylococcus aureus
Gardete, S., & Tomasz, A. (2014) · Journal of Clinical Investigation · doi:10.1172/jci68834 · Cited by 565
S South Yorkshire Hospitals Research Collaboration, Bateman, R. M., Sharpe, M. D., Jagger, J. E., Ellis, C. G., Solé-Violán, J., López-Rodríguez, M., Herrera-Ramos, E., Ruíz-Hernández, J., Borderías, L., et al. (2016) · Critical Care · doi:10.1186/s13054-016-1208-6 · Cited by 526
Antibiotic Resistance and the MRSA Problem
Vestergaard, M., Frees, D., & Ingmer, H. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0057-2018 · Cited by 490
Linezolid: a review of its properties, function, and use in critical care
Hashemian, S. M., Farhadi, T., & Ganjparvar, M. (2018) · Drug Design, Development and Therapy · doi:10.2147/dddt.s164515 · Cited by 459
Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA)
Mediavilla, J. R., Chen, L., Mathema, B., & Kreiswirth, B. N. (2012) · Current Opinion in Microbiology · doi:10.1016/j.mib.2012.08.003 · Cited by 397
Community-associated MRSA: What makes them special?
Otto, M. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.02.007 · Cited by 379
Physiologically Based Pharmacokinetic Modeling of Nanoparticles
Li, M., Al-Jamal, K. T., Kostarelos, K., & Reineke, J. (2010) · ACS Nano · doi:10.1021/nn1018818 · Cited by 351
Methicillin-resistant Staphylococcus aureus (MRSA): antibiotic-resistance and the biofilm phenotype
Craft, K. M., Nguyen, J. M., Berg, L. J., & Townsend, S. D. (2019) · MedChemComm · doi:10.1039/c9md00044e · Cited by 332
Cisek, A. A., Dąbrowska, I., Gregorczyk, K. P., & Wyżewski, Z. (2017) · Current Microbiology · doi:10.1007/s00284-016-1166-x · Cited by 318
Quenching the quorum sensing system: potential antibacterial drug targets
Kalia, V. C., & Purohit, H. J. (2011) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2010.532479 · Cited by 310
The cytotoxic Staphylococcus aureus PSMα3 reveals a cross-α amyloid-like fibril
Tayeb-Fligelman, E., Tabachnikov, O., Moshe, A., Goldshmidt-Tran, O., Sawaya, M. R., Coquelle, N., Colletier, J.-P., & Landau, M. (2017) · Science · doi:10.1126/science.aaf4901 · Cited by 304
The action mechanism of daptomycin
Taylor, S. D., & Palmer, M. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.05.052 · Cited by 298
Linezolid in vitro: mechanism and antibacterial spectrum
Livermore, D. M. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg249 · Cited by 269
Transfer of Antibiotic Resistance in Staphylococcus aureus
Haaber, J., Penadés, J. R., & Ingmer, H. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.05.011 · Cited by 265
Formation of the Protein Corona: The Interface between Nanoparticles and the Immune System
Barbero, F., Russo, L., Vitali, M., Piella, J., Salvo, I., Borrajo, M. L., Busquets-Fité, M., Grandori, R., Bastús, N. G., Casals, E., et al. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.10.001 · Cited by 263
Heidary, M., Khosravi, A. D., Khoshnood, S., Nasiri, M. J., Soleimani, S., & Goudarzi, M. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx349 · Cited by 236
Biofilms: Architecture, Resistance, Quorum Sensing and Control Mechanisms
Saxena, P., Joshi, Y., Rawat, K., & Bisht, R. (2019) · Indian Journal of Microbiology · doi:10.1007/s12088-018-0757-6 · Cited by 216
Approved Glycopeptide Antibacterial Drugs: Mechanism of Action and Resistance
Zeng, D., Debabov, D., Hartsell, T. L., Cano, R. J., Adams, S., Schuyler, J. A., McMillan, R., & Pace, J. L. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026989 · Cited by 211
Micek, S. T. (2007) · Clinical Infectious Diseases · doi:10.1086/519471 · Cited by 202
Persisters and beyond: Mechanisms of phenotypic drug resistance and drug tolerance in bacteria
Kester, J. C., & Fortune, S. M. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.869543 · Cited by 202
Antibiotics currently used in the treatment of infections caused by Staphylococcus aureus
RAYNER, C., & MUNCKHOF, W. J. (2005) · Internal Medicine Journal · doi:10.1111/j.1444-0903.2005.00976.x · Cited by 174
Contribution of the Immune Response to Phage Therapy
Krut, O., & Bekeredjian-Ding, I. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701745 · Cited by 172
Noguchi, N., Suwa, J., Narui, K., Sasatsu, M., Ito, T., Hiramatsu, K., & Song, J.-H. (2005) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45902-0 · Cited by 165
Molecular mechanisms and clinical implications of bacterial persistence
Michiels, J. E., Van den Bergh, B., Verstraeten, N., & Michiels, J. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.10.002 · Cited by 165
Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles
Li, M., Zou, P., Tyner, K., & Lee, S. (2017) · The AAPS Journal · doi:10.1208/s12248-016-0010-3 · Cited by 165
Khoshnood, S., Heidary, M., Asadi, A., Soleimani, S., Motahar, M., Savari, M., Saki, M., & Abdi, M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.131 · Cited by 144
Hospital-associated MRSA and antibiotic resistance—What have we learned from genomics?
Lindsay, J. A. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.02.005 · Cited by 133
The remarkably multifunctional fibronectin binding proteins of Staphylococcus aureus
Foster, T. J. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2763-0 · Cited by 130
Resistance of Group B Streptococcus to Selected Antibiotics, Including Erythromycin and Clindamycin
Heelan, J. S., Hasenbein, M. E., & McAdam, A. J. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.3.1263-1264.2004 · Cited by 128
Klein, E. Y., Mojica, N., Jiang, W., Cosgrove, S. E., Septimus, E. J., Morgan, D. J., & Laxminarayan, R. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix640 · Cited by 121
Multidrug efflux pumps in Staphylococcus aureus and their clinical implications
Jang, S. (2016) · The Journal of Microbiology · doi:10.1007/s12275-016-5159-z · Cited by 117
How does Staphylococcus aureus escape the bloodstream?
Edwards, A. M., & Massey, R. C. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2010.12.005 · Cited by 115
Genetic Diversity of norA, Coding for a Main Efflux Pump of Staphylococcus aureus
Costa, S. S., Sobkowiak, B., Parreira, R., Edgeworth, J. D., Viveiros, M., Clark, T. G., & Couto, I. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2018.00710 · Cited by 115
Severin, A. I., Tabei, K., Tenover, F. C., Chung, M., Clarke, N., & Tomasz, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309593200 · Cited by 107
Stefani, S., Campanile, F., Santagati, M., Mezzatesta, M. L., Cafiso, V., & Pacini, G. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.05.008 · Cited by 107
Lazaris, A., Coleman, D. C., Kearns, A., Pichon, B., Kinnevey, P. M., Earls, M. R., Boyle, B., O'Connell, B. C., Brennan, G. I., & Shore, A. C. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx292 · Cited by 99
Treatment of Methicillin-Resistant Staphylococcus aureus: Vancomycin and Beyond
Holmes, N. E., Tong, S. Y. C., Davis, J. S., & van Hal, S. J. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0034-1397040 · Cited by 93
Chuang, Y., Lin, H.-Y., Chen, P., Lin, C.-H., Wang, J., & Chang, S. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.07.018 · Cited by 82
Self-citationIron Chelation in Thalassemia Major
Borgna‐Pignatti, C., & Marsella, M. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.10.001 · Cited by 77
Biofilm-mediated Antibiotic-resistant Oral Bacterial Infections: Mechanism and Combat Strategies
Kanwar, I. L., Sah, A. K., & Suresh, P. K. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612822666161124154549 · Cited by 76
Andrade, J. C., Morais‐Braga, M. F. B., Guedes, G. M. D. M., Tintino, S. R., de Freitas, M. A., de Menezes, I. R. A., & Coutinho, H. D. M. (2014) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2014.10.011 · Cited by 73
Quinupristin‐Dalfopristin: An Overview
Delgado, G., Neuhauser, M. M., Bearden, D. T., & Danziger, L. H. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.19.1469.34858 · Cited by 72
Kime, L., Randall, C. P., Banda, F. I., Coll, F., Wright, J., Richardson, J., Empel, J., Parkhill, J., & O’Neill, A. J. (2019) · mBio · doi:10.1128/mbio.01755-19 · Cited by 71
Li, N., Luo, M., Fu, Y., Zu, Y., Wang, W. J., Zhang, L., Yao, L., Zhao, C., & Sun, Y. (2012) · Phytotherapy Research · doi:10.1002/ptr.4891 · Cited by 68
Phage Therapy: A New Horizon in the Antibacterial Treatment of Oral Pathogens
Shlezinger, M., Khalifa, L., Houri‐Haddad, Y., Coppenhagen‐Glazer, S., Resch, G., Que, Y., Beyth, S., Dorfman, E., Hazan, R., & Beyth, N. (2017) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666160930145649 · Cited by 67
Quorum sensing inhibition inPseudomonas aeruginosabiofilms: new insights through network mining
Pérez‐Pérez, M., Jorge, P., Rodríguez, G. P., Pereira, M. O., & Lourenço, A. M. G. (2017) · Biofouling · doi:10.1080/08927014.2016.1272104 · Cited by 67
Lekshmi, M., Parvathi, A., Adjei, J., Sanford, L. M., Shrestha, U., Kumar, S. H., & Varela, M. F. (2018) · AIMS Microbiology · doi:10.3934/microbiol.2018.1.1 · Cited by 67
Wang, Q., Yang, Q., & Wu, W. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.03139 · Cited by 67
Staphylococcus aureus: The enduring pathogen in surgery
Humphreys, H. (2012) · The Surgeon · doi:10.1016/j.surge.2012.05.003 · Cited by 55
The Battle for Iron between Humans and Microbes
Carver, P. L. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867324666170720110049 · Cited by 54
Lessa, F. C., Mu, Y., Ray, S. M., Dumyati, G. K., Bulens, S. N., Gorwitz, R. J., Fosheim, G. E., DeVries, A., Schaffner, W., Nadle, J., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis408 · Cited by 52
Zárate, S. G., Morales, P., Świderek, K., Bolaños-García, V. M., & Bastida, Á. (2019) · Antibiotics · doi:10.3390/antibiotics8010025 · Cited by 50
Novel linezolid resistance plasmids in Enterococcus from food animals in the USA
Tyson, G. H., Sabo, J. L., Hoffmann, M., Hsu, C.-H., Mukherjee, S., Hernandez, J., Tillman, G. E., Wasilenko, J. L., Haro, J., Simmons, M., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky369 · Cited by 45
Jokinen, E., Laine, J., Huttunen, R., Rahikka, P., Huhtala, H., Vuento, R., Vuopio, J., & Syrjänen, J. (2017) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2017.1292046 · Cited by 44
Rapid optical determination of β-lactamase and antibiotic activity
Khan, S., Sallum, U. W., Zheng, X., Nau, G. J., & Hasan, T. G. (2014) · BMC Microbiology · doi:10.1186/1471-2180-14-84 · Cited by 41
Allosteric Inhibition of a Mammalian Lectin
Aretz, J., Anumala, U. R., Fuchsberger, F. F., Molavi, N., Ziebart, N., Zhang, H., Nazaré, M., & Rademacher, C. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b08644 · Cited by 40
Shang, W., Hu, Q., Yuan, W., Cheng, H., Yang, J., Hu, Z., Yuan, J., Zhang, X., Peng, H., Yang, Y., et al. (2015) · Microbial Drug Resistance · doi:10.1089/mdr.2015.0226 · Cited by 37
Amberpet, R., Sistla, S., Sugumar, M., Nagasundaram, N., Manoharan, M., & Parija, S. (2019) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1976_17 · Cited by 32
Matano, L. M., Morris, H. G., Hesser, A. R., Martin, S. E. S., Lee, W., Owens, T. W., Laney, E., Nakaminami, H., Hooper, D. C., Meredith, T. C., et al. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b04726 · Cited by 30
Invasive community-associated MRSA infections: epidemiology and antimicrobial management
Pichereau, S., & Rose, W. E. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.511614 · Cited by 29
Martínez, N., Luque, R., Milani, C., Ventura, M., Bañuelos, Ó., & Margollés, A. (2018) · Applied and Environmental Microbiology · doi:10.1128/aem.02888-17 · Cited by 27
Staphylococcus aureus Resistance Patterns in Wisconsin
Schulte, R. H., & Munson, E. L. (2019) · Clinical Medicine & Research · doi:10.3121/cmr.2019.1503 · Cited by 26
Prevalence of tetracycline resistance determinants in broiler isolatedEscherichia coliin Iran
Seifi, S., & Khoshbakht, R. (2016) · British Poultry Science · doi:10.1080/00071668.2016.1232478 · Cited by 22
Absence of the Lectin Activation Pathway of Complement Ameliorates Proteinuria-Induced Renal Injury
Alghadban, S., Kenawy, H. I., Dudler, T., Schwaeble, W., & Brunskill, N. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02238 · Cited by 21
Matono, T., Nagashima, M., Mezaki, K., Motohashi, A., Kutsuna, S., Hayakawa, K., Ohmagari, N., & Kaku, M. (2017) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2017.10.014 · Cited by 13
Baseri, N., Peerayeh, S. N., & Amiri, F. B. (2018) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2018.06.018 · Cited by 13
Pharmacokinetic drug evaluation of ceftobiprole for the treatment of MRSA
Horn, K. S., Danziger, L. H., Rodvold, K. A., & Glowacki, R. C. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1303481 · Cited by 7
Cited by
Bacterial Antibiotic Resistance: The Most Critical Pathogens
Mancuso, G., Midiri, A., Gerace, E., & Biondo, C. (2021) · Pathogens · doi:10.3390/pathogens10101310 · Cited by 1,332
Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace
Chinemerem Nwobodo, D., Ugwu, M. C., Oliseloke Anie, C., Al‐Ouqaili, M. T. S., Chinedu Ikem, J., Victor Chigozie, U., & Saki, M. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24655 · Cited by 985
Bender, R. G., Sirota, S. B., Swetschinski, L. R., Dominguez, R.-M. V., Novotney, A., Wool, E. E., Ikuta, K. S., Vongpradith, A., Rogowski, E. L. B., Doxey, M., et al. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00176-2 · Cited by 596
Denissen, J., Reyneke, B., Waso-Reyneke, M., Havenga, B., Barnard, T., Khan, S., & Khan, W. (2022) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2022.114006 · Cited by 395
Biodegradable bone implants as a new hope to reduce device-associated infections-a systematic review
Paiva, J. C. C., Oliveira, L., Vaz, M. F., & Costa-de-Oliveira, S. (2022) · Bioengineering · doi:10.3390/bioengineering9080409 · Cited by 53
Metadata
- Authors
- Guo, Y., Song, G., Sun, M., Wang, J., & Wang, Y.
- Venue
- Frontiers in Cellular and Infection Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2020-03-17
- Volume
- 10
- Pages
- 107-107
- ISSN
- 2235-2988 (ISSN-L)
- OpenAlex
- W3012379779
- Cited by
- 870
- References
- 78
- FWCI
- 13.46
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.